« Back to Record
Mileva, M., de Vries, E. E., Guiot, T., Wimana, Z., Deleu, A.-L., Schröder, C. P., Lefebvre, Y., Paesmans, M., Stroobants, S., Huizing, M. T., Aftimos, P., Tol, J., Van Der Graaf, W. T. A., Oyen, W. J. G., Vugts, D., Menke-van der Houven van Oordt, W. C., Brouwers, A. A., Piccart-Gebhart, M., Flamen, P., & Gebhart, G. (2024). Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial). NPJ breast cancer, 10(1), 4. doi:10.1038/s41523-023-00610-6
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/371999



